SciSparc Ltd.

AI Score

0

Unlock

0.45
-0.01 (-3.16%)
At close: Feb 20, 2025, 3:59 PM
0.45
-1.11%
After-hours: Feb 20, 2025, 06:26 PM EST
undefined%
Bid 0.43
Market Cap 4.66M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -5.28
PE Ratio (ttm) -0.09
Forward PE n/a
Analyst n/a
Ask 0.46
Volume 147,481
Avg. Volume (20D) 8,869,923
Open 0.46
Previous Close 0.46
Day's Range 0.43 - 0.47
52-Week Range 0.20 - 4.29
Beta undefined

About SPRC

SciSparc Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include SCI-110 for the treatment of Tourette syndrome, obstructive sleep apnea, and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; and SCI-210 for the treatment of autism spectrum disorder and epilepsy. The company has an agreement with Procaps to develop and commercially manufactur...

Industry Biotechnology
Sector Healthcare
IPO Date Aug 30, 2021
Employees 3
Stock Exchange NASDAQ
Ticker Symbol SPRC
Full Company Profile
1 month ago
+102.69%
SciSparc and Clearmind Medicine shares are trading... Unlock content with Pro Subscription
1 month ago
SciSparc shares are trading higher after the company announced it received its first shipment of vehicles manufactured by Anhui Jianghuai Automobile Group.